An Update on Gene Therapy for Primary Immunodefciencies
Christinne Kinnon, London, UK
08.05
10.00
Intravenous Immunoglobulin Reimbursement in the Czech Republic
Anna Sediva, Prague, Czech Republic
08.05
10.15
Different Therapeutic Approaches in CGD Patients with Infectious Deteriorations
Elizaveta Galkina, Moscow, Russia
08.05
10.30
Treatment of a Patient with Complete diGeorge/CHARGE Syndrome
Ales Janda, Prague, Czech Republic
08.05
11.00
Children’s Memorial Health Institute Experience in Management of Children with Primary Immunodeficiencies after Haematopoietic Stem Cell Transplantation
Beata Wolska-Kusnierz, Warsaw, Poland
08.05
13.00
ADA Deficiency
Renata Formankova, Prague, Czech Republic
08.05
13.15
Late Onset of Severe Combined Immunodeficiency
Bernadett Mosdosi, Pecs, Hungary
08.05
13.30
SCID Patient with Generalised BCG-itis, Haemophagocytosis, EBV-lymphoma after Three Bone Marrow Transplantations
Anna Yurasova, Moscow, Russia
08.05
13.45
Case Report of a XLP Patient
Peter Ciznar, Bratislava, Slovakia
08.05
14.00
The ESID Online Registry – Status and Perspectives
Benjamin Gathmann, Freiburg, Germany
08.05
14.30
Perspectives of IPOPI - The International Organization for Patients with PID
Eva Soergel, Nuremberg, Germany
09.05
09.00
An Update on Common Variable Immunodeficiency
Helen Chapel, Oxford, United Kingdom
09.05
09.05
T- and B-lymphocyte Subpopulations in Patients with Selective IgA Deficiency
Jiri Litzman, Brno, Czech Republic
09.05
09.45
Relations between T- and B- Lymphocyte Abnormalities in CVID Patients and Their Age Dependency
Marcela Vlkova, Brno, Czech Republic
09.05
10.00
Molecular Genetic Analysis of the Gene Encoding TACI in Czech Patients with IgAD and CVID
Tomas Freiberger, Brno, Czech Republic
09.05
10.15
Anti-galactosyl Natural Antibodies in the Patients with Antibody Deficiency
Marketa Hamanova, Brno, Czech Republic
09.05
10.30
Immunoglobulin substitution, products of Baxter Bioscience Division
Miroslav Hlauco, Prague, Czech Republic
09.05
10.45
BTK Mutation Affects Cytokine Production After Viral RNA Recognition in Myeloid Dendritic Cell
Klara Sochorova, Prague, Czech Republic
09.05
11.00
Primary Immunodeficiencies in Adults (Lithuanian experience)
Audra Blaziene, Vilnius, Lithuania
09.05
11.15
Common Variable Immunodeficiency in Adults
Kestutis Cerniauskas, Vilnius, Lithuania
09.05
11.30
Retrospective Case Studies of sIgAD Patients
Zoltan Ellenes-Jakabffy, Oradea, Romania
09.05
11.45
Primary Antibody Deficiencies in Estonia
Sirje Velbri, Tallin, Estonia
09.05
13.30
Cernunnos Deficiency - Case Report
Edyta Heropolitańska – Pliszka, Warsaw, Poland
09.05
13.45
Immune Response and Hormonal Alterations in C1-inhibitor Deficiency
Vojtech Thon, Brno, Czech Republic
09.05
14.00
Autoimmune Presentations in Chromosome Breakage Syndromes